JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index
Original Article
The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience
Aims: Sepsis is a life-threatening organ dysfunction resulting from an excessive inflammatory response in the host due to infection. Due to the activation of the coagulation system in sepsis, the search for treatment has shifted in this direction and therapeutic plasma exchange (TPE). This study, it was aimed to compare the hemogram and biochemical values and inflammatory markers of patients who underwent TPE before and after TPE.
Methods: The research data were obtained retrospectively from the records on the hospital system of the patients who were hospitalized in Malatya İnönü University Faculty of Medicine Intensive Care Clinic and were treated with TPE.
Results: A total of 25 patients were included. It was observed that platelet count (p=0.427), hemoglobulin (p=0.545), leukocyte (p=0.527) and neutrophil (p=0.657) counts decreased statistically after TPE. It was observed that C-reactive protein (p=0.065) and procalcitonin (p=0.267) values also decreased after TPE procedure. Among the direct bilirubin (p=0.326), total bilirubin (p=0.397), AST (p=0.840) and alanine transferase(ALT) (p=0.122) values, it was determined that the aspartate transferase (AST) value increased after the TPE procedure and the others decreased. It was observed that the blood urea nitrogen (p=0.326) value increased after TPE procedure, while creatinine (p=0.677) value decreased.
Conclusion: TPE process can reduce harmful components in plasma. Since it is of vital importance to reduce harmful components in the plasma in sepsis, TPE can be applied by evaluating patient-specifically. Our study is important in terms of showing that TPE can be an alternative treatment modality in patients with sepsis and septic shock.


1. Jameson JL, Anthony SF , Dennis LK, Stephen LH, Dan LL, JosephL. Harrison 20th edition, 2020, united states, section 2 medicalemergencies,14 sepsis and septic shock. 2022;(21):68-70.
2. Zanon F, Caovilla JJ, Michel RS, et al. Sepsis in the intensive care unit:etiologies, prognostic factors and mortality. Rev Bras Ter Intensiva.2008;(20):128-134.
3. Ullah AR, Hussain A, Ali I, et al. A prospective observational studyassessing the outcome of sepsis in intensive care unit of a tertiary carehospital, peshawar. Pak J Med Sci. 2021;32(3):688.
4. Polat G, Ugan R A, Cadirci E, Halici Z. Sepsis and septic shock:current treatment strategies and new approaches. Eurasian J Med.2017;49(1):53.58.
5. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis insevere sepsis and septic shock: a prospective, randomised, controlledtrial.Med Intensiva. 2002;28(10):1434-1439.
6. Çopuroğlu E. «Protokole dayalı tedavinin ağır sepsis mortalitesiüzerine etkisi.»Journal of the Turkish Society of Intensive. Crit CareMed. 2011;(28):1-89.
7. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, andoutcome of severe sepsis and septic shock in adults: a multicenterprospective study in intensive care units.Jama. 1995;(12):968-974.
8. Bodur HA, Koca U. Ağır sepsistemortaliteyi etkileyen faktörler. Tark.2005;(26):90-98.
9. Baykara N, Akalın H, Arslantaş MK, et al. Epidemiology of sepsisin intensive care units in Turkey: a multicenter, point-prevalencestudy.Critical Care. 2018;22(1):1-14.
10. Buisson CB, Meshaka P, Pinton P, Vallet B. EPISEPSIS: a reappraisal ofthe epidemiology and outcome of severe sepsis in French intensive careunits.Med Intensiva. 2004;(30):580-588.
11. Arslan Ö, Arat M, Göktürk S, Ayyildiz E, İlhan O. Therapeutic plasmaexchange and the clinical applications.Turk J Haematol. 2003;20(1):7-17.
12. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange:complications and management.Am J Kidney Dis. 1994,23(6):817-827.
13. Polat M, Ceylan B, Alanoğlu G, Eroğlu F, Sipahi T. SüleymanDemirel Üniversitesi Hastanesi Yoğun Bakım Ünitesi plazma ferezuygulamaları.SDÜ Tıp Fakültesi Derg. 2009;16(4):1-4.
14. Padmanabhan A. Guidelines on the use of therapeutic apheresis inclinical practice -evidence-based approach from the writing committeeof the American society for apheresis: the eighth special ıssue. J ClinApher. 2019;(34):171-354.
15. Weinstein R. Therapeutic apheresis in neurological disorders. J ClinApher. 2000;(15):74-128.
16. Norda R, Berseus O, Stegmayr B. Adverse events and problems intherapeutic hem apheresis. a report from the swedish registry. TransfusApher Sci. 2001;(25):33-41.
17. Bozkaya Y. Terapötika ferez işlemlerinin değerlendirilmesi; retrospektifve prospektif veri toplama çalışması 2013.
18. Knaus WA, Draper EA, Wagner DP, Wagner DP. APACHE II: a severityof disease classification system. Crit Care Med. 1985;(10):818-829.
19. Çakalot Ü. 2019.Erzurum Atatürk Üniversitesi Tıp Fakültesinde son beşyıl içinde (Ocak 2013 ve Ocak 2018 tarihleri arasında) terapötikplazmaferez yapılan hastaların klinik ve laboratuar bulguları(Masters thesis,Sağlık Bilimleri Enstitüsü).
20. Yetimoğlu H. 2011-2015 yılları arasında aferez merkezinde yapılanterapötika ferez işlemlerinin klinik ve laboratuvar bulgularınındeğerlendirilmesi 2016.
21. Tutarel O, Golla P, Beutel G, et al. Therapeutic plasma exchangedecreases levels of routinely used cardiac and inflammatorybiomarkers.PLoS One. 2012;7(6):38573.
22. Hadem J, Hafer C, Schneider AS, et al. Therapeutic plasma exchangeas rescue therapy in severe sepsis and septic shock: retrospectiveobservational single-centre study of 23 patients.BMC Anesthesiol. 2014;(1):1-10.
Volume 2, Issue 3, 2024
Page : 67-71
_Footer